WinstonWınston
Genufood Energy Enzymes logo

Genufood Energy Enzymes

GFOO
Shell Companies · Financial Services
Price
$0.00
+0.00 (+0.00%)
Market Cap
$80,890
Winston Score
Winston looking sleepy
No score yet — Winston is napping.
We couldn’t gather enough financial data to score this stock reliably.

Share count rising — dilution

+1055.4% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 70.0M (2019) → 808.9M (2023)

Genufood Energy Enzymes Corp. is a very small company that has described itself as focused on enzyme-based food and health products, targeting consumers interested in digestive health supplements. It is classified as a shell company, meaning it currently has little to no active business operations generating real revenue. The company has not established a clear, functioning product line or customer base at this time.

The company reports essentially zero revenue and zero gross profit, and its return on invested capital is deeply negative, meaning it is destroying far more value than it creates. It appears to operate primarily in Asia, but its actual commercial footprint is minimal. The biggest risk here is that the company may never develop into a functioning operating business — shell companies often exist as vehicles for future mergers or acquisitions rather than as standalone enterprises, and there is no guarantee any such transaction will occur or benefit shareholders.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

+83.3% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

Research and development spending

Insider Activity

39.3%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~3 months

$125,924 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Cash watch

Genufood Energy Enzymes has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
N/A
Data not available
Operating Margin
N/A
Data not available
ROCE
-193.2%
Weak — -193.2% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
N/A
Data not available
EPS YoY
N/A
Data not available
EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
Data not available
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial